Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
about
The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled TrialInactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America.Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach.Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission.Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.Maximising the impact of inactivated polio vaccines.Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infantsThe risk of type 2 oral polio vaccine use in post-cessation outbreak response.Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine.Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan.Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs
P2860
Q33553771-96791B0A-B975-47EE-95CF-1BBAF3F322CFQ33777684-D72899B2-A313-410A-859F-38930890CEF0Q39014586-7657686F-293C-4F24-A679-8E66A96C01E4Q39426840-47CDA248-3E57-4496-9B6C-1B6A589307A8Q40071754-0B8181E5-CED5-43A6-92E8-2A6FB2ED1F25Q40128598-208F4BC9-5BF3-4EB4-BC66-E37AAB160776Q40222691-D442F166-E9F2-4E0F-A72D-18EEAA8DA5FFQ40537256-F9D46D6B-6A54-45A8-93C0-6A0F5582EDCDQ41925239-FE4DC57E-7F79-4D77-85B5-D4247103182EQ47106477-AC07A3B6-5BBB-43ED-871B-6D298D0275DDQ47198460-7DD51053-92FC-41E4-9E6C-57B36CFC1B22Q47583783-CC9FC002-7333-4061-8292-85E4245ACECFQ55114845-3FF087A8-64B4-48D0-A077-5B25FEAD376BQ58599406-7FE966C3-744D-4938-8102-A703E76400E3
P2860
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Humoral and intestinal immunit ...... l randomised controlled trial.
@en
type
label
Humoral and intestinal immunit ...... l randomised controlled trial.
@en
prefLabel
Humoral and intestinal immunit ...... l randomised controlled trial.
@en
P2093
P50
P1433
P1476
Humoral and intestinal immunit ...... el randomised controlled trial
@en
P2093
Bhavesh R Borate
Chris Gast
Eduardo Lopez
James T Gaensbauer
José Jimeno
Latin American IPV001BMG Study Group
Luis Rivera
M Steven Oberste
Mario Melgar
P304
P356
10.1016/S0140-6736(16)00703-0
P407
P577
2016-05-19T00:00:00Z